Primary information |
---|
ID | antitb_1994, |
Name | 26352292 |
N-Terminal modification | VpAmp2.0 |
C-Terminal Modification | FWGFLGKLAMKAVPSLIGGNKSSSK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 25 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
Cell Line | MIC= 21.4 ± 7.5 µM |
Inhibition Concentration | In vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | Cell wall |
PMID | NA |
Year of Publication | Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus agalactiae |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1995, |
Name | 26352292 |
N-Terminal modification | VpAmp2.0 |
C-Terminal Modification | FWGFLGKLAMKAVPSLIGGNKSSSK |
Chemical Modification | Free |
Linear/Cyclic | Free |
Length | None |
Chirality | Linear |
Nature | 25 |
Source | L |
Origin | Cationic |
Species | Synthetic |
Inhibition Concentration | Mycobacterium tuberculosis |
In Vitro/ In vivo | Mycobacterium tuberculosis MDR |
Cell Line | MIC= 30.5 ± 9.5 µM |
Inhibition Concentration | In vitro |
Sequence | 2015 |
Cytotoxicity | NA |
In vivo Model | NA |
Lethal Dose | NA |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | Cell wall |
PMID | NA |
Year of Publication | Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus agalactiae |
Tertiary Structure (Technique) | Not Predicted), |